CNIO (Spanish National Cancer Centre), Melchor Fernandez Almagro 3, 28029 Madrid, Spain.
Biochem J. 2011 Mar 15;434(3):549-58. doi: 10.1042/BJ20101410.
p38α MAPK (mitogen-activated protein kinase) plays an important tumour suppressor role, which is mediated by both its negative effect on cell proliferation and its pro-apoptotic activity. Surprisingly, most tumour suppressor mechanisms co-ordinated by p38α have been reported to occur at the post-translational level. This contrasts with the important role of p38α in the regulation of transcription and the profound changes in gene expression that normally occur during tumorigenesis. We have analysed whole-genome expression profiles of Ras-transformed wild-type and p38α-deficient cells and have identified 202 genes that are potentially regulated by p38α in transformed cells. Expression analysis has confirmed the regulation of these genes by p38α in tumours, and functional validation has identified several of them as probable mediators of the tumour suppressor effect of p38α on Ras-induced transformation. Interestingly, approx. 10% of the genes that are negatively regulated by p38α in transformed cells contribute to EGF (epidermal growth factor) receptor signalling. Our results suggest that inhibition of EGF receptor signalling by transcriptional targets of p38α is an important function of this signalling pathway in the context of tumour suppression.
p38α MAPK(丝裂原活化蛋白激酶)发挥着重要的肿瘤抑制作用,这是通过其对细胞增殖的负向影响和促凋亡活性来介导的。令人惊讶的是,大多数由 p38α 协调的肿瘤抑制机制已被报道发生在翻译后水平。这与 p38α 在转录调控中的重要作用以及肿瘤发生过程中通常发生的基因表达的深刻变化形成对比。我们分析了 Ras 转化的野生型和 p38α 缺陷细胞的全基因组表达谱,鉴定出 202 个在转化细胞中可能受 p38α 调控的基因。表达分析证实了这些基因在肿瘤中的 p38α 调控,功能验证鉴定出其中一些基因可能是 p38α 对 Ras 诱导转化的肿瘤抑制作用的潜在介质。有趣的是,在转化细胞中受 p38α 负向调控的基因中,约有 10%与表皮生长因子受体(EGF)信号通路有关。我们的研究结果表明,p38α 转录靶基因对 EGF 受体信号通路的抑制是该信号通路在肿瘤抑制中的一个重要功能。